One-year Efficacy and Safety of Dulaglutide in Patients with Type 2 Diabetes and Chronic Kidney Dise...
One-year Efficacy and Safety of Dulaglutide in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Study of Asian Patients
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Highlights•Dulaglutide has proven efficacy and safety in patients with diabetic kidney disease. •Dulaglutide showed sustained efficacy during the initial 1 year of treatment. •Dulaglutide could be a favorable long-term therapeutic option for patients with diabetic kidney disease.
Alternative Titles
Full title
One-year Efficacy and Safety of Dulaglutide in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Study of Asian Patients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3085685681
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3085685681
Other Identifiers
ISSN
0149-2918,1879-114X
E-ISSN
1879-114X
DOI
10.1016/j.clinthera.2024.06.024
